baber/WOPTO huggingface dataset:
Patent AU-4739896-A (AU)
Title: Method and associated device for removing material from body
Inventor: GELBFISH GARY A
IPC: A61M1/00
Filed: 1995-12-15
Abstract: A method for removing a clot utilizes a surgical instrument or device including an elongate tubular member having a most distal first opening, a relatively central second opening and a most proximal third opening all spaced from each other along the tubular member. The distal end of the tubular member is inserted through a skin surface of a patient into a subcutaneous blood vessel or vascular bypass and subsequently out of the vascular component and the skin surface so that the first opening and the third opening are located outside the patient while the second opening is located in the vascular component. Upon completed insertion of the device, suction is applied to one of the openings outside the patient to thereby draw a blood clot in the blood vessel or vascular bypass towards the second opening which is disposed in the vessel, graft or bypass. Upon a drawing of the clot at least partially into the tubular member through the second opening, a portion of the clot is severed inside the tubular member and is subsequently removed from the tubular member through the suction opening in the tubular member.
Patent AU-4788293-A (AU)
Title: System for detection of electrically conductive fluids
Inventor: FISHER LARRY F
IPC: A61F5/48
Filed: 1993-07-20
Abstract: Apparatus for detecting the presence of electrically conductive fluids, including urine and other body fluids such as exudates from wounds, includes spaced-apart electrodes (44, 46, 96, 98) covered by absorbent material (58, 106, 108, 126, 128), together with a housing (30, 86, 154) containing a signaling device (32, 152, 172, 175) which produces a palpable vibration, a sound, a light, or a radio signal when fluid in the absorbent material provides a conductive path between the electrodes. Spring contacts (50, 138, 146) on the housing provide reliable connections with the electrodes and also serve to attach the housing of the signaling device (32) to structure (12, 78) supporting the adsorbent material, and may also be used to attach the adsorbent material to the housing in embodiments where the housing is otherwise supported. Encoded signals from many such sensors (160, 170) can be identifiably related to and recorded so as to be machine-retrievable together with other patient data and analyzed statistically by a computer (178, 183).  <IMAGE>
Patent AU-4851885-A (AU)
Title: Liquid quality monitor
Inventor: PITT GILLIES DAVID
IPC: G01N21/53
Filed: 1985-10-11
Abstract: A power station boiler condensate water monitor employs a light-scatter cell (4) for the detection of oil and/or particulates in the water. In order to determine background scatter levels, provision is made to alternatively pass clean water through the cell (FLUSH). The offset voltages obtained from the detector outputs when clean water is employed are compensated for differences in temperature between the boiler condensate water and the clean water before subtraction from the detector outputs when boiler condensate water is employed. The monitor is capable of detecting oil levels of less than 2 ppm.
Patent AU-5000699-A (AU)
Title: Flame retardant microporous polymeric foams
Inventor: DYER JOHN COLLINS
IPC: C08J9/28
Filed: 1999-07-16
Abstract: Disclosed are microporous, open-celled polymeric foams formed by polymerizing a high internal phase water-in-oil emulsion comprising a continuous oil phase and discontinuous water phase where the foam has a Limiting Oxygen Index (LOI) value of at least about 18% Such foams are commonly known in the art as "HIPEs". The foams have a variety of flame retardant applications, including use in insulation.
Patent AU-5063301-A (AU)
Title: Method for generating intra-particle morphological concentration / density maps and histograms of a chemically pure particulate substance
Inventor: MOSHE DANNY S
IPC: G01N15/14
Filed: 2001-04-19
Abstract: An method for generating intra-particle morphological concentration/density maps and histograms of a chemically pure particulate substance. Spectral imaging, in general, and focus-fusion multi-layer spectral imaging, in particular, combined with pattern recognition classification analysis are performed on individual particles for forming sets of single-particle spectral fingerprint data, characterized by single-particle spectral fingerprint spectra. Spectral shifts are identified in the single-particle spectral fingerprint data, for forming intra-particle region groups featuring sub-sets of intra-particle spectral fingerprint pattern data, each characterized by an intra-particle spectral fingerprint pattern spectrum. Each intra-particle region group is associated with different types of intra-particle morphological regions, where each region type is associated with a surface concentration value and a density value of the chemically pure substance in that imaged particle, for forming intra-particle morphological concentration/density data, which is used for generating an intra-particle morphological concentration/density map. A morphological concentration/density histogram, or frequency distribution, is generated from the intra-particle morphological concentration/density data, for illustrating global morphological distribution of concentration, and density of the chemically pure substance throughout the entire multi-particle substance.
Patent AU-5095990-A (AU)
Title: A method for cleansing streptokinases
Inventor: EINARSSON MONICA
IPC: C07K14/315
Filed: 1990-02-05
Abstract: The invention relates to the cleansing of streptokinase, by causing the streptokinase in solution to bind to a gel which consists of a matrix containing hydrophobic ligands, whereafter the bound streptokinase is eluted from the gel.
Patent AU-5256190-A (AU)
Title: Ball-type water sprinkler
Inventor: GREENBERG ILAN
IPC: B05B3/16
Filed: 1990-04-03
Abstract: A ball-type water sprinkler of the sector type includes tow inlets (21,22) into the ball chamber (18) oriented to direct the water to flow in opposite directions circumferentially around the chamber (18), and a shutter (24) rotatable with the rotor (16) and movable either to a first position with respect to the rotor (16) covering one inlet and uncovering the other inlet to cause the water to flow in a first direction, or to a second position uncovering the one inlet and covering the other inlet to cause the water to flow in the opposite direction. The shutter (24) is actuated by a member (36) rotatable with the rotor (16) and cooperable with the sector stops (38,40) of the sprinkler, the actuator (36) being coupled to the shutter (24) by an over-center spring coupling (42) producing a snap-action movement of the shutter (36) to either its first or second positions.
Patent AU-5340294-A (AU)
Title: Thermoplastic structural system and components therefor and method of making same
Inventor: DEZEN VITTORIO
IPC: E04F17/08
Filed: 1993-05-27
Abstract: A thermoplastic wall forming member (14') is provided with rails (39) for securing a wiring channel (40) interiorly of a hollow wall structure to be formed by the wall forming member and other wall forming members.
Patent AU-5463886-A (AU)
Title: Disposable waste containment garment
Inventor: BUELL KENNETH BARCLAY
IPC: A61F13/15
Filed: 1986-03-12
Abstract: A disposable waste containment garment which is particularly useful and leakage resistant for bedridden incontinent adults. The garment has side-edge-leakage-guard gutters having closed ends, and longitudinally elasticized distal edges. The gutters and the other garment elements are configured and disposed to substantially obviate inversion or unfolding of the gutters during application and use of the garment. The garment is sized and configured so that, when secured on a user, the elasticized distal edges of the gutters will normally extend along the groin regions of the user, and diverge upwardly across abdominal, hip and lower back areas of the user rather than encircling the thighs of the user. The absorbent core of the garment is preferably sufficiently resilient to cause it to stand away from some lower abdominal and hip regions of the user. This, in conjunction with the gutters being sufficiently flexible and elasticized, causes adjacent portions of the gutters to be biased open. These open portions of the gutters are, in fact, reservoirs which substantially obviate leakage by containing free liquid during urination events when fluid is received in the garment faster than it can be absorbed in the absorbent core of the garment, or whenever free liquid is squeezed out of a portion of the garment as when the weight of a bedridden user is shifted. The ends of the gutters in the waistband regions of the garment may be sealed liquid tight, or be secured closed with edge portions of the absorbent core and/or topsheet disposed therein, or a combination of such sealing and securing.
Patent AU-5491186-A (AU)
Title: Method of and apparatus for breaking up pollen
Inventor: ULRICH GRUNHOFF
IPC: A23L21/20
Filed: 1986-03-18
Abstract: A process and apparatus for releasing blossom pollen from its outer skin by a combination of drying and size reduction pressure treatment steps.
Patent AU-5528594-A (AU)
Title: A method for charging bore-holes with explosive
Inventor: ENGSBRATEN BJORN
IPC: E21D9/00
Filed: 1994-02-22
Abstract: A method for charging explosives in substantially horizontal bore-holes, with a loading density reduced in relation to that corresponding to the complete fill up of the bore-hole diameter with the explosive in bulk form, comprising that a charging hose with an end opening is introduced into at least one bore-hole of a blasting round, that a pumpable and coherent bulk explosive is pumped through the charging hose at a controlled rate, that simultaneous with the pumping of explosive the hose is withdrawn at a controlled rate, that the pumping and withdrawal rates are adjusted to form a coherent string exiting from the hose end opening, said exiting string only partially filling up the bore-hole diameter. An apparatus for charging explosives in bore-holes in controlled volume amount per bore-hole length unit comprises, a vessel (31) containing a pumpable and coherent bulk explosive (32), a charging hose (45) adappted for insertion into the hole-hole, a conduit (38) connecting the vessel with the hose, pumping means (33,34) for moving the explosive from the vessel through the conduit and the hose at a controlled rate, hose moving means (44,48) allowing forward movement of the hose and withdrawal of the hose at a controlled rate and adjusting means (34,48) for setting the ratio between pumping rate and hose withdrawal rate. <IMAGE>
Patent AU-5541600-A (AU)
Title: Optimal video decoder based on mpeg-type standards
Inventor: BARLAUD MICHEL
IPC: H04N7/30
Filed: 2000-06-09
Abstract: The invention concerns a process for decompression of compressed animated images with a method including treatment of images in blocks and containing a digital data recomposition phase defining predefined forms, a phase modeling the movement of these forms using a process of prediction, interpolation and temporal compensation, an image composition phase from reconstructed elements of JPEG or MPEG type motion, characterized by the fact that the form recomposition phase includes a process for separating fixed forms from mobile forms, a process for recording digital data corresponding to the fixed forms treated by a filter not separable from the processes implemented in the recomposition phase in a first specific memory unit and digital data corresponding to mobile forms in a second specific memory unit.
Patent AU-5894386-A (AU)
Title: Membrane anchor/active compound conjugate, its preparation and its use
Inventor: JUNG GUNTHER
IPC: C07K7/00
Filed: 1986-06-23
Abstract: Conjugates are described in which the active ingredient is covalently bonded to the anchoring membrane, which is a compound of the formulae   <IMAGE> in which A can be: sulphur, oxygen, disulphide (-S-S-), methylene (-CH2-) or -NH-; n = 0 to 5; m = 1 or 2; C* = an asymmetric carbon atom of R or S configuration, R, R' and R'' are identical or different and are an alkyl, alkenyl or alkynyl group having 7 to 25 carbon atoms or are hydrogen which can optionally be substituted by hydroxyl, amino, oxo, acyl, alkyl or cycloalkyl groups and R1 and R2 are identical or different and are defined as R, R' or R'' or can be -OR, -OCOR, -COOR, -NHCOR or -CONHR and X is an active ingredient or a spacer active ingredient group. The anchoring membrane active ingredient conjugates increase antibody formation.
Patent AU-5955190-A (AU)
Title: Pestivirus nucleotide sequences and polypeptides
Inventor: MOORMAN ROBERTUS JACOBUS MARIE
IPC: C12P21/02
Filed: 1990-06-29
Abstract: A method of protecting a subject, in particular a domestic animal, against a microbial infection comprises the use of a combination of a nucleotide sequence coding for an antigen related to the infection and a stop transfer nucleotide sequence. A method of constructing a transgenic animal which is resistant to the infectious organism comprises incorporating a nucleotide sequence related to the infection in the genome of the animal. The method is especially useful for providing protection against a pestivirus infections such as hog cholera (swine fever). Also provided are nucleotide sequences and vector constructs thereof, and polypeptides useful for producing vaccines and for diagnosis. A diagnostic method is given which differentiates between infected animals and vaccinated animals.
Patent AU-6100390-A (AU)
Title: Substituted 1-azabicyclo(3.1.1) heptanes
Inventor: WYMAN PAUL ADRIAN
IPC: A61K31/00
Filed: 1990-08-14
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof: <CHEM>  in which Z is a heterocyclic group <CHEM> in which Q represents a 3-membered divalent residue completing a 5-membered aromatic ring and comprises one or two heteroatoms selected from oxygen, nitrogen and sulphur, or three nitrogen atoms, any amino nitrogen being substituted by a C1-2 alkyl, cyclopropyl or propargyl group, and any ring carbon atom being optionally substituted by a group R1; or a group <CHEM> in which A1, A2 and A3 complete a 5-membered aromatic ring and A1 is oxygen or sulphur, one of A2 and A3 is CR2 and the other is nitrogen or CR3, or A2 is oxygen or sulphur, one of A1 and A3 is CR2 and the other is CR3; and R1, R2 and R3 are independently selected from hydrogen, halogen, CN, OR4, SR4, N(R4)2, NHCOR4, NHCOOCH3, NHCOOC2H5, NHOR4, NHNH2, NO2, COR4, COR5, cyclopropyl, C2-5 straight chain alkenyl, C2-5 straight chain alkynyl or C1-5 straight chain alkyl optionally terminally substituted with OR4, N(R4)2, SR4, CO2R4, CON(R4)2 or one, two or three halogen atoms, in which each R4 is independently hydrogen or C1-3 alkyl and R5 is OR4, NH2 or NHR4; or in which Z is a group -C(R7)=NR6 in which R6 is a group OR8, where R8 is C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, a group OCOR9 where R9 is hydrogen or R8, or a group NHR10 or NR11R12 where R10, R11 and R12 are independently C1-2 alkyl and R7 is hydrogen or C1-4 alkyl, subject to the proviso that when R6 is a group OCOR9 or NHR10, R7 is C1-4 alkyl.
Patent AU-6193298-A (AU)
Title: Electrodeless lamp with bulb rotation
Inventor: WOOD CHARLES H
IPC: H01J17/20
Filed: 1998-04-17
Abstract: An electrodeless lamp comprises an envelope (12) containing a plasma forming fill which includes at least one of sulfur and selenium when excited which emits principally visible light, which is in the form of molecular radiation. The envelope (12) has a diameter of less than one half inch. Means (1) are provided for generating electromagnetic energy. Further means (2, 3, 4, 5, 6) are provided for coupling said electromagnetic energy to said envelope to excite said fill, which in the absence of envelope rotation or with rotation at an insufficient speed, forms a discharge (14) which does not substantially fill the interior volume of said envelope (12). By additional means (13) the envelope (12) is rotated at a fast enough rate so as to cause the discharge (15) formed by the fill to substantially fill the interior volume of the envelope (12). <IMAGE>
Patent AU-6316796-A (AU)
Title: Use of lamellarin-class alkaloids in methods of treatment
Inventor: PUENTES JOSE LUIS FERNANDEZ
IPC: A61K31/435
Filed: 1996-06-26
Abstract: The lamellarin compounds disclosed herein have been found to be inhibitors of MDR, i.e., acquired multidrug resistance, which has become a major problem in the treatment of various cancers. The lamellarin compounds disclosed herein have also been found to be cytotoxic to MDR cells. MDR is believed to be associated with certain alterations in tumor cells, including an over-expression of a certain high molecular weight membrane glycoprotein and a decrease in the ability of the tumor cell to accumulate and retain chemotherapeutic agents. The present invention is thus directed to methods of treating MDR-type tumors with an effective anti-MDR amount (either inhibitory or cytotoxic) of one or more lamellarin compounds, which compounds have been found to be effective antitumoral agents against MDR cells.
Patent AU-6342500-A (AU)
Title: Classification engine in a cryptography acceleration chip
Inventor: KRISHNA SURESH
IPC: H04L29/06
Filed: 2000-07-07
Abstract: Provided is an architecture for a cryptography accelerator chip that allows significant performance improvements over previous prior art designs. In various embodiments, the architecture enables parallel processing of packets through a plurality of cryptography engines and includes a classification engine configured to efficiently process encryption/decryption of data packets. Cryptography acceleration chips in accordance may be incorporated on network line cards or service modules and used in applications as diverse as connecting a single computer to a WAN, to large corporate networks, to networks servicing wide geographic areas (e.g., cities). The present invention provides improved performance over the prior art designs, with much reduced local memory requirements, in some cases requiring no additional external memory. In some embodiments, the present invention enables sustained full duplex Gigabit rate security processing of IPSec protocol data packets.
Patent AU-6343200-A (AU)
Title: Amido spiropiperidines promote the release of growth hormone
Inventor: TATA JAMES R
IPC: C07D401/12
Filed: 2000-07-10
Abstract: The present invention is directed to certain spiropiperidines of the general structural formula:wherein R1, R2, R3, R3a, R3b, R4 and R5 are as defined herein. These compounds promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such compounds as the active ingredient thereof are also disclosed.
Patent AU-6391698-A (AU)
Title: Rising platform, specially for a motor vehicle, and method for its production
Inventor: THIELOW FRANK
IPC: B66B7/02
Filed: 1998-02-06
Abstract: Disclosed is a rising platform, specially for a motor vehicle, which can be economically produced with little effort. According to the invention, this is done in that at least a bearing column (1) comprises a shaped body (3) which consists at least partially of a flowable, hardenable material.
Patent AU-6401494-A (AU)
Title: Treatment of tumors with compounds having rxr retinoid receptor agonist activity
Inventor: DAVIES PETER A J
IPC: A61P35/04
Filed: 1994-03-10
Abstract: The invention provides the use of a compound which has retinoid like activity and is an agonist of RXR retinoid receptors, for the manufacture of a medicament for inducing apoptotic death of tumor cells in a host mammal thereby to treat the tumor.
Patent AU-6517890-A (AU)
Title: Cell separation invention
Inventor: SOON-SHIONG PATRIC
IPC: A61K35/12
Filed: 1990-09-18
Abstract: An aqueous composition and a method of use are disclosed for the separation of different living cells, such as pancreatic islet and acinar cells. The composition comprises a water soluble, metabolically inert substance to control density, osmolarity and pH; a physiological cold storage solution containing viscosity modifiers to increase the viscosity and osmotically active, impermeant agents to suppress cold-induced edema; all in a medium capable of maintaining viable cells. The solutions are combined to provide a first solution with a density greater than both cell types in their natural state but less than the second cell type after incubation in said solution; and a second solution with a density less than that of both cell types. Separation is achieved by allowing the system to stand or by centrifugation.
Patent AU-6670196-A (AU)
Title: Thienopyrimidine derivatives, their production and use
Inventor: FURUYA SHUICHI
IPC: C07D495/04
Filed: 1996-08-13
Abstract: A thienopyrimidine derivative, wherein it has: (1) a carboxyl group which may be esterified and (2) a group which is capable of forming an anion or a group convertible thereinto except carboxyl group in its molecule, such as a compound of formula (I'), wherein each of R<1> and R<2> are hydrogen or an optionally substituted hydrocarbon residue, R<3> is a C1-6 alkyl group which is substituted by a C1-6 alkoxy-carbonyl group or a group of the formula: -NH-SO2-R<5>, wherein R<5> is : (1) a C1-6 alkyl group which may optionally be substituted by halogen or (2) a C6-14 aryl group, R<4> is an optionally substituted hydrocarbon residue or an optionnally substituted heterocyclic group, W denotes a chemical bond or a spacer group and n denotes an integer of 1 to 3; or a salt thereof, exhibits high endothelin receptor antagonist action and can, therefore, be used with advantager as a prophylactic or therapeutic drug for acute renal failure, myocardial infarction, lever disorder, angina pectoris, cerebral infarction, cerebrovasospasm, hypertension, kidney disease, asthma, ectopic angina, Raynaud's syndrome, pulmonary hypertension, surgical shock, chronic heart failure, atherosclerosis, cardiac hyperthrophy, migraine, etc., as a prophylactic or therapeutic drug for organ surgery- or graft-associated hypofunction of organs, as a prophylactic drug for vascular restenosis following percutaneous transluminal coronary angioplasty (PTCA), or as an inhibitor for vasoconstriction of cerebrovascular system or pulmonary vascular system.
Patent AU-6743596-A (AU)
Title: Receiving method and receiver
Inventor: PIIRAINEN OLLI
IPC: H04L1/06
Filed: 1996-08-28
Abstract: The invention relates to a receiving method in a digital cellular radio system. The invention further relates to a receiver of the cellular radio network. In computing the signal to noise ratio, a reference signal is utilized which is the convolution of the estimated impulse response of a channel and the predetermined sequence. The signal to noise ratio is obtained as a ratio between the variance of the reference signal and the predetermined sequence received from the channel. The signal to noise ratio is used for weighing the diversity branches of the diversity receiver.
Patent AU-6876891-A (AU)
Title: Immunosuppressant and process for preparing the same
Inventor: NAGASE HIROSHI
IPC: A61K31/485
Filed: 1990-11-28
Abstract: The immunosuppressants comprises a delta-opioid antagonist or its salt. The antagonist is preferably of formula (I) or (II) R1 = 1-5C alkyl, 3-6C cycloalkylalkyl, 5-7C cycloalkenylalkyl, aryl, aralkyl, 4-5C transalkenyl, allyl or furan-2-yl alkyl. R2 = H, OH or 1-5C alkanoyloxy. R3 = H, 1-5C alkyl or 1-5C alkanoyl. X = O, S or NY. Y = H or 1-5C alkyl. R4, R5 = H, F, Cl, Br, NH2, NO2, 1-5C alkyl or 1-5C alkoxy, or R4 + R5 = benzyl. M = N or CH2. Dosage is 0.001-1 g/day, preferably 0.01-10 g/day.